Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism

Alzheimer’s disease (AD) is a progressive neurological illness characterized by memory loss and cognitive deterioration. Dapagliflozin was suggested to attenuate the memory impairment associated with AD; however, its mechanisms were not fully elucidated. This study aims to examine the possible mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Samman, Waad A., Selim, Salma M., El Fayoumi, Hassan M., El-Sayed, Norhan M., Mehanna, Eman T., Hazem, Reem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223357/
https://www.ncbi.nlm.nih.gov/pubmed/37242536
http://dx.doi.org/10.3390/ph16050753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223357/
https://www.ncbi.nlm.nih.gov/pubmed/37242536
http://dx.doi.org/10.3390/ph16050753

Ejemplares similares